Company & Sponsor Intelligence
New York Institute of Technology
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting0
Completed2
Countries1
Therapeutic footprint
parkinsons
Indexed studies
NCT03307161Osteopathic Manual Treatment Parkinson's Disease and Truncal Dystonia
parkinsons · United StatesNA
parkinsons · United StatesNA
NCT03622840Impact of Individual Cognitive Remediation for Parkinson's Disease
parkinsons · United StatesNA
parkinsons · United StatesNA
NCT01676103The Effects of Supplementing Tyrosine on Blood Pressure in Parkinson's Disease
parkinsons · United StatesPHASE1, PHASE2
parkinsons · United StatesPHASE1, PHASE2
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →